AKILI, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4272 USD | -3.87% |
|
+6.37% | -12.30% |
| 04-30 | Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product | CI |
| 04-30 | Akili, Inc. to Reduce Workforce | CI |
- Stock Market
- Equities
- AKLI Stock
- News Akili, Inc.
- Transcripts
